CORRESPONDENCE
Letter regarding the article ‘Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis’
First published: 09 April 2025
No abstract is available for this article.
References
- 1Karakasis P, Lefkou E, Pamporis K, Farmakis D, Patoulias D, Antoniadis AP, Heymans S, Filippatos G, Fragakis N Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Eur J Heart Fail 2025. https://doi.org/10.1002/ejhf.3637. Published online ahead of print 10/03/25.
- 2Díez-Díez M, Ramos-Neble BL, de la Barrera J, Silla-Castro JC, Quintas A, Vázquez E, et al. Unidirectional association of clonal hematopoiesis with atherosclerosis development. Nat Med 2024; 30: 2857–2866. https://doi.org/10.1038/s41591-024-03213-1
- 3Bick AG, Pirruccello JP, Griffin GK, Gupta N, Gabriel S, Saleheen D, et al. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 2020; 141: 124–131. https://doi.org/10.1161/CIRCULATIONAHA.119.044362
- 4Qiu X, Dai Y, Cheng S, Gu HQ, Jiang Y, Meng X, et al. Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: A prospective cohort study. Stroke Vasc Neurol 2023; 8: 103–110. https://doi.org/10.1136/svn-2022-001756
- 5Yao CY, Ko TY, Yang LT, Takeuchi M, Yeh CF, Lin MS, et al. Clonal hematopoiesis is associated with adverse clinical outcomes and left ventricular remodeling in aortic stenosis. JACC Adv 2025; 4:101532. https://doi.org/10.1016/j.jacadv.2024.101532
